Corpovael Valuation Multiples

Discover revenue and EBITDA valuation multiples for Corpovael and similar public comparables like Amrep, Deutsche Fachmarkt, TRX Real Estate FII, BRPR Corporate Offices and more.

Corpovael Overview

About Corpovael

Corpovael SA de CV is engaged in developing, building and commercializing accessible housing for the middle and lower level of the Mexicans. The company seeks new investment alternatives in other States of the Republic in order to provide a home for more Mexicans.


Founded

2007

HQ

Mexico

Employees

N/A

Financials (LTM)

Revenue: $308M
EBITDA: $46M

EV

$261M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Corpovael Financials

Corpovael reported last 12-month revenue of $308M and EBITDA of $46M.

In the same LTM period, Corpovael generated $72M in gross profit, $46M in EBITDA, and $22M in net income.

Revenue (LTM)


Corpovael P&L

In the most recent fiscal year, Corpovael reported revenue of $297M and EBITDA of $31M.

Corpovael is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 11%, and net margin of 8%.

See analyst estimates for Corpovael
LTMLast FY202320242025202620272028
Revenue$308M$297M$265M$264M$297M
Gross Profit$72M$70M$72M$70M$70M
Gross Margin23%24%27%27%24%
EBITDA$46M$31M$33M$28M$31M
EBITDA Margin15%11%13%11%11%
EBIT Margin9%9%12%10%9%
Net Profit$22M$24M$17M$14M$24M
Net Margin7%8%7%5%8%
Net Debt-$75M---

Financial data powered by Morningstar, Inc.

Corpovael Stock Performance

Corpovael has current market cap of $124M, and enterprise value of $261M.

Market Cap Evolution


Corpovael's stock price is $0.42.

Corpovael share price decreased by 1.7% in the last 30 days, and increased by 148.3% in the last year.

Corpovael has an EPS (earnings per share) of $0.08.

See more trading valuation data for Corpovael
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$261M$124M-2.8%-1.7%-7.2%148.3%$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Corpovael Valuation Multiples

Corpovael trades at 0.8x EV/Revenue multiple, and 5.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Corpovael

EV / Revenue (LTM)


Corpovael Financial Valuation Multiples

As of August 20, 2026, Corpovael has market cap of $124M and EV of $261M.

Corpovael has a P/E ratio of 5.6x.

LTMLast FY202320242025202620272028
EV/Revenue0.8x0.9x1.0x1.0x0.9x
EV/EBITDA5.7x8.3x7.9x9.4x8.3x
EV/EBIT9.2x9.5x8.5x10.2x9.5x
EV/Gross Profit3.7x3.7x3.6x3.7x3.7x
P/E5.6x5.1x7.1x9.1x5.1x
EV/FCF-7.5x3.4x23.9x7.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Corpovael Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Corpovael Margins & Growth Rates

Corpovael grew revenue by 6% but net profit decreased by 13% in the last fiscal year.

In the most recent fiscal year, Corpovael reported gross margin of 24%, EBITDA margin of 11%, and net margin of 8%.

See estimated margins and future growth rates for Corpovael

Corpovael Margins

Last FY202420252026202720282029
Gross Margin24%27%24%23%
EBITDA Margin11%11%11%-
EBIT Margin9%10%9%9%
Net Margin8%5%8%7%
FCF Margin12%4%12%-

Corpovael Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%(0%)13%6%
Gross Profit Growth3%(2%)0%3%
EBITDA Growth-(16%)13%-
EBIT Growth6%(17%)8%6%
Net Profit Growth(13%)(22%)77%(13%)
FCF Growth-(86%)221%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Corpovael Operational KPIs

Access forward-looking KPIs for Corpovael
LTMLast FY202320242025202620272028
Rule of 4021%----
Bessemer Rule of X29%----
S&M Expenses to Revenue-8%9%10%8%
G&A Expenses to Revenue-0%0%0%0%
Opex to Revenue-14%15%17%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Amrep1.4x1.4x5.6x6.1x
Deutsche Fachmarkt11.5x9.8x14.7x16.1x
TRX Real Estate FII5.2x---
BRPR Corporate Offices6.1x-5.9x-
Balwin Properties1.9x-12.1x-
Daidoh0.8x0.8x12.9x-
Riza Akin FII5.4x---
Polski Holding Nieruchomoƛci2.6x-8.5x-

This data is available for Pro users. Sign up to see all Corpovael competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Corpovael

When was Corpovael founded?Corpovael was founded in 2007.
Where is Corpovael headquartered?Corpovael is headquartered in Mexico.
Is Corpovael publicly listed?Yes, Corpovael is a public company listed on Bolsa Mexicana de Valores.
What is the stock symbol of Corpovael?Corpovael trades under CADUA ticker.
When did Corpovael go public?Corpovael went public in 2015.
Who are competitors of Corpovael?Corpovael main competitors include Amrep, Deutsche Fachmarkt, TRX Real Estate FII, BRPR Corporate Offices, Balwin Properties, Daidoh, Riza Akin FII, Polski Holding Nieruchomoƛci, FCR Immobilien, Fortinova Fastigheter.
What is the current market cap of Corpovael?Corpovael's current market cap is $124M.
What is the current revenue of Corpovael?Corpovael's last 12 months revenue is $308M.
What is the current revenue growth of Corpovael?Corpovael revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Corpovael?Current revenue multiple of Corpovael is 0.8x.
What is the current EBITDA of Corpovael?Corpovael's last 12 months EBITDA is $46M.
What is Corpovael's EBITDA margin?Corpovael's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Corpovael?Current EBITDA multiple of Corpovael is 5.7x.
How many companies Corpovael has acquired to date?Corpovael hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Corpovael has invested to date?Corpovael hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Corpovael

Lists including Corpovael

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial